Company Performance Metrics
- Mark Li: President & CEO
Resolution Bioscience is pioneering next-generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy. Resolution Bioscience's proprietary molecular analytics platform interrogates cell-free DNA for actionable information that, until now, has only been accessible through
invasive biopsy procedures.
Resolution Bioscience has developed over 50 focused panels and is currently working on companion diagnostics to support therapeutic approvals.
Resolution Bioscience is dedicated to improving cancer outcomes through a suite of clinical tests to guide the selection of targeted therapies and monitor their effectiveness over time.